BETTER THERAPEUTICS
Better Therapeutics discovers, develops, and commercializes prescription digital therapeutics for the treatment of cardiovascular and metabolic diseases. They use clinically-validated, FDA-regulated software to change the behaviors that cause these diseases to aid in quality of life, reducing the need for medications, and lowering costs. Their products deliver digital behavioral therapy that integrates neuroscience, lifestyle medicine, and explainable AI into a physician-prescribed mobile medical app and uses patient-generated data to inform clinical decision-making and improve treatment outcomes. Their current product pipeline includes therapeutic candidates for the treatment of type 2 diabetes, hypertension, and dyslipidemia.
BETTER THERAPEUTICS
Industry:
Artificial Intelligence (AI) Biotechnology Health Care MHealth Therapeutics
Founded:
2015-04-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.bettertx.com
Total Employee:
51+
Status:
Active
Contact:
(415) 887-2311
Email Addresses:
[email protected]
Total Funding:
150.53 M USD
Technology used in webpage:
Domain Not Resolving SPF Google Font API Content Delivery Network Mobile Non Scaleable Content Google Apps For Business Microsoft Azure DNS Apple Mobile Web App Capable Cloudflare CDN ReCAPTCHA V2
Similar Organizations
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Strados Labs
Strados Labs innovates respiratory monitoring using smart biosensors and artificial intelligence.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
TowerView Health
TowerView Health develops an application for patients to manage medications.
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Sectoral Asset Management
Sectoral Asset Management investment in Post-IPO Equity - Better Therapeutics
RS Investments
RS Investments investment in Post-IPO Equity - Better Therapeutics
Farallon Capital Management
Farallon Capital Management investment in Post-IPO Equity - Better Therapeutics
Monashee Investment Management
Monashee Investment Management investment in Post-IPO Equity - Better Therapeutics
Hercules Capital
Hercules Capital investment in Debt Financing - Better Therapeutics
Key Employee Changes
Official Site Inspections
http://www.bettertx.com Semrush global rank: 5.01 M Semrush visits lastest month: 1.65 K
Unable to get host informations!!!
More informations about "Better Therapeutics"
Better Therapeutics - LinkedIn
Better Therapeutics ("Better") is developing first-in-class prescription digital therapeutics to deliver behavioral therapy to patients. Led by an experienced team of biotechnology executives with ...See details»
Better Therapeutics - Overview, News & Similar companies
Nov 27, 2023 View Better Therapeutics (www.bettertx.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Better Therapeutics, Inc. (BTTX) - Yahoo Finance
See the company profile for Better Therapeutics, Inc. (BTTX) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Better Therapeutics Announces Submission for FDA Breakthrough …
SAN FRANCISCO, January 02, 2024--Better Therapeutics, Inc. (NASDAQ: BTTX), a pioneer in developing prescription digital therapeutics (PDTs) to treat cardiometabolic diseases, today …See details»
Better Therapeutics Company Description - Stock Analysis
Nov 8, 2024 Better Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases.See details»
Better Therapeutics Announces it will Seek Strategic …
SAN FRANCISCO, March 14, 2024--Better Therapeutics, Inc. (NASDAQ: BTTX) (the "Company") announced today that the Company is terminating its employees and will explore strategic alternatives ...See details»
Better Therapeutics Receives FDA Breakthrough Device …
Feb 20, 2024 For more information visit: bettertx.com About AspyreRx AspyreRx (formerly BT-001) was granted marketing authorization by the FDA in July 2023 as the first prescription-only …See details»
Better Therapeutics Trust Center | Powered by Conveyor
Bettertx.com. Founded 2015. Report a vulnerability. There’s additional information available for approved Better Therapeutics customers and prospects. Request or Regain Access. Badges. …See details»
Better Therapeutics Receives FDA Authorization for AspyreRx™ to …
Jul 10, 2023 Better Therapeutics, Inc. (NASDAQ: BTTX), a pioneer in developing software to treat cardiometabolic diseases, today announced that the Food and Drug ASee details»
Better Therapeutics Receives FDA Breakthrough Device …
Feb 20, 2024 For more information visit: bettertx.com. About AspyreRx. AspyreRx (formerly BT-001) was granted marketing authorization by the FDA in July 2023 as the first prescription-only …See details»
Better Therapeutics Signs Rebate Agreement with One of the …
SAN FRANCISCO, February 06, 2024--Better Therapeutics Inc. (NASDAQ: BTTX), a pioneer in developing prescription digital therapeutics (PDTs) for treating cardiometabolic diseases, …See details»
Better Therapeutics to Release Third Quarter 2023 Financial …
Nov 8, 2023 Better Therapeutics, Inc. (NASDAQ: BTTX), a pioneer in developing prescription digital therapeutics to treat cardiometabolic diseases, today announcedSee details»
Better Therapeutics Announces an Innovative Partnership with the ...
Mar 5, 2024 For media inquiries, please contact [email protected] For partnership inquiries or further information, please contact [email protected] Source: Better Therapeutics, Inc. Analyze …See details»
Better Therapeutics Announces an Innovative Partnership with the ...
SAN FRANCISCO, March 05, 2024--Better Therapeutics, Inc. (NASDAQ: BTTX), a pioneer in developing prescription digital therapeutics (PDTs) for treating cardiometabolic diseases, …See details»
Better Therapeutics and Glooko Announce Partnership to …
Jan 4, 2024 For more information visit: bettertx.com About AspyreRx AspyreRx (formerly BT-001) was granted marketing authorization by the FDA in July 2023 as the first prescription-only …See details»
Better Therapeutics - Facebook
Better Therapeutics. 7,566 likes · 1 talking about this. Better Therapeutics is a prescription digital therapeutics (PDT) company delivering a novel form...See details»
Better Therapeutics and Glooko Announce Partnership to …
Jan 4, 2024 SAN FRANCISCO & PALO ALTO, Calif., January 04, 2024--Better Therapeutics Inc. (NASDAQ: BTTX), a pioneer in developing prescription digital therapeutics (PDTs) for …See details»
Better Therapeutics, Inc. (BTTX) Stock Price, News, Quote & History ...
Find the latest Better Therapeutics, Inc. (BTTX) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Better Therapeutics, Inc. (BTTX) - Yahoo Finance
Find the latest Better Therapeutics, Inc. (BTTX) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»